A new study analyzing medical records of over 2 million veterans found a possible association between popular GLP-1 drugs like Ozempic and an increased risk of damage to the kidneys, pancreas, and digestive system. While these drugs offer benefits for weight management and diabetes treatment, the study highlights the need for further research to fully understand their long-term effects.
Scientists have discovered a possible association between popular drugs such as Ozempic and an increased risk of damage to the kidneys, pancreas and the digestive system.Weight-loss medications called glucagon-like peptide-1 receptor agonists include Ozempic, Mounjaro, Wegovy and Zepbound—and they can be prescribed for obesity or type 2 diabetes.
GLP-1 works by mimicking the natural fullness hormone GLP-1 and one of the ways it works is by slowing down digestion, as well as supporting blood sugar balance, reducing appetite and dulling dopamine responses to food.'Interestingly, GLP-1RA drugs act on receptors that are expressed in brain areas involved in impulse control, reward and addiction—potentially explaining their effectiveness in curbing appetite and addiction disorders,' said Al-Aly.
GLP-1 DRUGS OZEMPIC PANCREATITIS KIDNEY DISEASE DIGESTIVE PROBLEMS
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
6 Best Weight Loss Treatments: Ranking Top Weight Loss Solutions of 2025Affiliate. Explore the top six weight loss brands currently on the market in 2025.
Read more »
I’m a weight loss doctor—the unusual complication I’m seeing from Ozempic-like drugsA top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like Ozempic.
Read more »
Medicare to Negotiate Prices for Weight Loss Drugs Ozempic and WegovyThe Biden administration announced that popular weight loss drugs Ozempic and Wegovy will be included in Medicare's price negotiation program. This move is expected to result in billions of dollars in savings for taxpayers, with negotiations handled by the incoming Trump administration.
Read more »
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight lossGLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, whether they utilize weight loss drugs or not,” IBX said in a statement.
Read more »
Ozempic: Weight-Loss Drug's Benefits And Risks Revealed in New StudyThe Best in Science News and Amazing Breakthroughs
Read more »
Ozempic: A Weight Loss Wonder Drug or a Troubling Trend?The author explores the controversial rise of Ozempic for weight loss, questioning its long-term effects and societal implications.
Read more »